pre-update Archives

Poster

Dynamic Target-Mediated Drug Disposition (TMDD)

Abstract Methods: We have developed a novel pharmacokinetic model, termed dynamic TMDD, to mechanistically describe the…

Renee Fisher2024年9月16日

Poster

Semi-mechanistic Model of ATG-101, a PD-L1/4-1BB Bispecific Antibody, for Treatment of Solid Tumors

Abstract Trimer formation is key to the pharmacology of the bispecific ATG-101 but is difficult…

Renee Fisher2024年9月16日

Poster

Blinatumomab Trimer Formation

Insights from a Mechanistic PKPD Model on the Implications for Switching from Infusion to Subcutaneous…

Renee Fisher2024年9月16日

On-Demand Webinar

定量的システム薬理学（QSP）により、腫瘍学における初のヒトを対象とした研究が可能に

Renee Fisher2024年9月16日

Article

Industry Sense – Drug Repurposing Unlocking New Therapeutic Possibilities

Panelists: Adekemi Taylor, PhD, VP, Quantitive Science Services at CertaraJoab Williamson, Director of Clinical Operations,…

Certara2024年9月16日

Publication

A tutorial on physiologically based pharmacokinetic approaches in lactation research

The tutorial by Amita Pansari, Xian Pan, Lisa M. Almond, and Karen Rowland-Yeo examines the…

Danielle Pillsbury2024年9月16日

Blog

All You Need to Know About Non-CRF Data in Clinical Trials

We look at the role of non-CRF data in clinical trials, and best practices for…

Certara2024年9月16日

Blog

The SDTM Mapping Process Simplified

SDTM mapping can be one of the most challenging programming problems in a clinical trial…

Certara2024年9月16日

SDTM Supplemental Qualifiers - blog post by Certara

ブログ

What Are SDTM Supplemental Qualifiers?

We touched on the SDTM supplemental qualifier in the SDTM mapping process simplified. In this…

Certara2024年9月16日

Video

From Development to Patient Impact: Biohaven’s Nurtec™ Success Story

To learn more about Biohaven's success story, read our case study. 事例

Certara2024年9月13日

pre-update

Dynamic Target-Mediated Drug Disposition (TMDD)

Semi-mechanistic Model of ATG-101, a PD-L1/4-1BB Bispecific Antibody, for Treatment of Solid Tumors

Blinatumomab Trimer Formation

定量的システム薬理学（QSP）により、腫瘍学における初のヒトを対象とした研究が可能に

Industry Sense – Drug Repurposing Unlocking New Therapeutic Possibilities

A tutorial on physiologically based pharmacokinetic approaches in lactation research

All You Need to Know About Non-CRF Data in Clinical Trials

The SDTM Mapping Process Simplified

What Are SDTM Supplemental Qualifiers?

From Development to Patient Impact: Biohaven’s Nurtec™ Success Story

メルマガ登録

クイックアクセス

ソリューション

お問合せ